Varex Imaging (VREX) 2025 Conference June 04, 2025 08:10 AM ET Speaker0 The med tech analyst at Jefferies. Thanks for coming to our conference. I'm very excited to have management from Verix Imaging here as well. So to my immediate left, you got Sany Sanyal, the CEO, and next to him, the CFO, Sam Maheshwari. Thank you gentlemen for coming, and I'm looking forward to a good discussion. I guess to start, maybe a little bit high level. So, you know, you guys are leaders in CT and x-ray tubes and detectors. You ...

VAREX IMAGING (VREX) reported $212.9 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 3.3%. EPS of $0.26 for the same period compares to $0.16 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $206.83 million, representing a surprise of +2.93%. The company delivered an EPS surprise of +85.71%, with the consensus EPS estimate being $0.14.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall ...

VAREX IMAGING (VREX) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.16 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 85.71%. A quarter ago, it was expected that this company would post earnings of $0.04 per share when it actually produced earnings of $0.07, delivering a surprise of 75%.Over the last four quarters, the company has s ...

Varex Imaging (VREX) Q2 2025 Earnings Call May 08, 2025 05:00 PM ET Company Participants Christopher Belfiore - Director-Investor RelationsSunny Sanyal - President & Chief Executive OfficerShubham Maheshwari - Chief Financial OfficerYoung Li - Senior VP - Equity ResearchShaymus Contorno - Equity Research AssociateBrandon Carney - Senior Research Associate Conference Call Participants Larry Solow - Partner & Managing director - Equity AnalystAlex Hantman - AnalystSaurabh Prasad - Senior Credit Analyst Operat ...

Varex Imaging (VREX) Q2 2025 Earnings Call May 08, 2025 05:00 PM ET Speaker0 and welcome to the Verix Q2 Fiscal Year twenty twenty five Call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce you to your host Chris Balfour, Director of Investor Relations. Thank you, Chris. You may begin. Speaker1 Good afternoon and welcome to Verix Imaging Corporatio ...

Making the Invisible Visible Q2 FY25 Earnings Presentation May 8, 2025 5/8/2025 1 Forward Looking Statements This supplement contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning financial results; earnings guidance; tariffs and trade wars and their impact on our customers; industry or business outlook, including for our business in China; product demand; payoff of our convertible debt; expected future financial results or per ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________ FORM 10-Q ____________________________________________________________ For the quarterly period ended April 4, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-37860 ____________ ...

Exhibit 99.1 VAREX ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2025 SALT LAKE CITY, May 8, 2025 – Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2025. 2QFY25 Summary Balance Sheet & Cash Flow Cash flow from operations was $17 million in the second quarter of fiscal year 2025. Cash, cash equivalents, and marketable securities at the end of the second quarter of fiscal year 2025 was $226 million, excluding the $125 ...

Company Overview - VAREX IMAGING (VREX) shares increased by 16.5% to close at $8.69, following a significant volume of trading, contrasting with a 41.8% loss over the past four weeks [1] - The recent stock price increase is attributed to a relief rally in global markets due to a 90-day pause on tariff hikes announced by the United States [1] Earnings Expectations - VAREX IMAGING is expected to report quarterly earnings of $0.14 per share, reflecting a year-over-year decline of 12.5% [2] - Revenue projections stand at $206.83 million, indicating a slight increase of 0.3% compared to the same quarter last year [2] Stock Performance Insights - The consensus EPS estimate for VAREX IMAGING has remained unchanged over the last 30 days, suggesting that stock price movements may not sustain without trends in earnings estimate revisions [3] - The stock currently holds a Zacks Rank of 3 (Hold), indicating a neutral outlook [3] Industry Context - VAREX IMAGING operates within the Zacks Medical - Products industry, alongside TriSalus Life Sciences, Inc. (TLSI), which saw a minor increase of 0.2% to $5.50 in the last trading session [3] - TriSalus Life Sciences has experienced a 7.9% return over the past month, with its EPS estimate changing by -2% to -$0.20, representing a 63% improvement from the previous year [4]

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.On top of the ...